ML-SA5

Research use only, not for human use.

ML-SA5 is an MCOLN1 agonist and arrests autophagic flux by perturbing fusion between autophagosomes and lysosomes.

ML-SA5 is an MCOLN1 agonist and arrests autophagic flux by perturbing fusion between autophagosomes and lysosomes.(In Vitro):Activating MCOLN1 with ML-SA5 triggers cell death of a number of cancer cells by evoking autophagic arrest and subsequent apoptotic response and cell cycle arrest, with little or no effect observed on normal cells.(In Vivo):ML-SA5 in Patu 8988 t xenograft mice profoundly suppresses tumor growth and improves survival.

ML-SA5(1-100 μM, 24 h) has some cell-targeting specificity and induces substantial cell death in M12 and MeWo cells, but fully preserves normal melanocytes. It also causes a loss of mitochondrial membrane potential in M12 cells.

ML-SA5 (i.p., 2-5 mg/kg, daily, 2 weeks) reduces muscle necrosis in MDX mice by more than 70% and reduces central nucleated fibers, suggesting that ML-SA5 can improve muscle atrophy in mdx mice in vivo by promoting myosin repair, but has no effect in ML1 knockout mice. Moreover, ML-SA5 reduces skeletal and cardiac muscle damage in mdx mice through ML1 upregulation.

——

Autophagy

Autophagy

——

——

——

2418670-70-7

457.99

C19H24ClN3O4S2

>98% (HPLC)

In Vitro:?DMSO : 125 mg/mL (272.93 mM)

O=S(=O)(NC=1C=CC=C(Cl)C1N2CCCCC2)C3=CC=C(C=C3)S(=O)(=O)N(C)C

——

(-20℃)

With Ice Pack

≥ 2 years